Duorui Medicine (301075.SZ): Currently, all workshops built by Xinchengda have been put into production, and the production operation situation is normal.

On January 10, Gelonghui reported that Duori Pharmaceutical (301075.SZ) stated on the investor interaction platform that all the workshops of Xinchengda have been put into production, and the production and Operation situation is normal. For specific details, please pay attention to the company's announcements and regular reports.

Gelonghui FinanceJan 10 17:12

Duori Pharmaceutical (301075.SZ): Own products have not yet been developed for influenza or antiviral treatment.

Gelonghui, January 10 - Duory Pharmaceutical (301075.SZ) stated on the investor interaction platform that the company's ibuprofen suspension is produced based on a sales-driven production model, and the company's own products have not yet been developed for the treatment of influenza or viral infections.

Gelonghui FinanceJan 10 17:08

Express News | Duoyuan Pharmaceutical: Acetate Ringer's injection is expected to be selected for centralized procurement.

BreakingsDec 16, 2024 15:50

Express News | DuoRui Pharmaceutical: Sodium Bicarbonate Injection Accepted for Pharmaceutical Registration.

BreakingsNov 19, 2024 18:07

Express News | Dorothy Pharmaceutical: Sichuan Frontier Ertan Active Pharmaceutical Ingredient approved for listing and passed pharmaceutical GMP compliance inspection

BreakingsNov 6, 2024 19:31

Express News | Doray Pharma: Subsidiary plans to acquire sichuan frontier active pharmaceutical ingredient approved for listing.

BreakingsNov 6, 2024 19:27